India-Korea collaboration to strengthen Maritime Workforce and Industrial Competitiveness (See 'Corp Brief') Govt approves Rs.132.5 Crore for Critical Port Connectivity Project at Kandla (See 'Corp Brief') India's Seafood Exports: From Growth to Global Competitiveness (See 'Corp Brief') CAQM's Enforcement Task Force reviews inspection outcomes, enforcement actions (See 'Corp Brief') Karmayogi Sadhana Saptah brings Ministries, States and Training Institutions Together (See 'Corp Brief') GoI signs Agreement to provide SAMPANN 'platform-as-a-service' to State Government of Goa (See 'Corp Brief') Ministry of Coal reports Record-Breaking Production (See 'Corp Brief') PTC Saharanpur not just an Institution but a Living Legacy of Service: Scindia (See 'Corp Brief') IPR - Failure of party to file opposition to registration of trademark u/s 21 of Trade Marks Act, does not disentitle such genuinely aggrieved party from subsequently seeking revocation, cancellation, or rectification of said trademark: HC (See 'Legal Desk') Geological Survey of India concludes Field Season in Mineral Exploration (See 'Corp Brief') IndiaAI and CDSCO launch Health Innovation Acceleration Hackathon (See 'Corp Brief') West Asia crisis: Customs duty exemption granted to petrochemical products (See 'Corp Brief') PC Act - If other materials on record are creditworthy and reliable, there would be no bar on relying on same for arriving at conclusion regarding guilt of accused: HC (See 'Legal Desk') Chouhan launches landmark Initiative to Unite Policy, Science, and Field Experience on One Platform (See 'Corp Brief') BCGCL and MCL sign Landmark Land Leasing Agreement for Coal to Ammonium Nitrate Project (See 'Corp Brief') IPR - Plaintiff's failure to conclusively establish its exclusive proprietorship over trademarks, coupled with evidence of joint ownership & authorization letter produced by Defendant, meant that matter required full trial: HC (See 'Legal Desk') Railways sets New Record in Passenger Traffic as well as Cargo Transport (See 'Corp Brief') NHAI achieves Robust Growth in NH Development During FY 2025-26 (See 'Corp Brief') PMLA - If specific property was inadvertently omitted in impugned order, case must be remanded back to Adjudicating Authority for limited purpose of passing specific order: SAFEMA (See 'Legal Desk') Nyaya Setu AI Chatbot and Mascot 'DISHIKA' unveiled at DISHA Programme (See 'Corp Brief') Misc - Recipient of concession has no legally enforceable right against Government to grant of concession except to enjoy benefits of concession during period of its grant: SC (See 'Legal Desk') After Signing reformed linked MoU, 5 States got funds under Jal Jeevan Mission 2.0 (See 'Corp Brief') India's largest collaborative Capacity Building Initiative Begins on 2nd April (See 'Corp Brief') IPR - Section 19 of Trade Marks Act, does not permit any third party to make application before Registrar for withdrawal of acceptance of trademark application: HC (See 'Legal Desk') MSME Ministry organizes Entrepreneur Awareness Camp in Dimapur (See 'Corp Brief') Govt and RBI Measures ensure Seamless Rural Credit Flow (See 'Corp Brief') DGCA signs MoU with Gati Shakti Vishwavidyalaya to train youth (See 'Corp Brief') Record 30 Mineral Blocks operationalised in FY 2025-26 (See 'Corp Brief') IPR - No infringement action will lie at instance of one registered proprietor of trade mark against another registered proprietor, seeking injunction against use, by latter, in class in which it is registered: HC (See 'Legal Desk') NCL achieves 140 MT Coal Production Target Ahead of Schedule (See 'Corp Brief') Jan Dhan Darshak App enables GIS-based monitoring of banking infrastructure (See 'Corp Brief') Gati Shakti Vishwavidyalaya & DGCA sign MoU to Revamp Aircraft Maintenance & Create Jobs (See 'Corp Brief') Benami Act - registration of title, payment of stamp duty, deposit of TDS, and routing of payments through banking channels do not negate benami nature of transaction if source of funds originates from another person: SAFEMA (See 'Legal Desk') Goyal meets UK Secretary of State for Business and Trade (See 'Corp Brief') Access Control & AI-Enabled CCTV Systems to streamline Passenger Flow at Railway stations (See 'Corp Brief') IPR - Order passed by Controller of Patents, which lacks independent analysis and is verbatim reproduction of submissions of one party or recommendations of Opposition Board, is procedurally flawed: HC (See 'Legal Desk') Gut Microbiota and Probiotic Science Foundation organises 16th India Probiotic Symposium (See 'Corp Brief') IPR - Overall appearance at first impression is crucial to identify passing off, and meticulous side-by-side dissection is not necessary and trade dress has to be judged as whole: HC (See 'Legal Desk') Supreme Court Clears Path For Single Insolvency Proceedings Against Linked Group Companies (See CORP EINSICHT)

Print

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.